| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 60,082 | 56,662 | 48,560 | 48,644 |
| Cost of goods sold | 14,089 | 14,644 | 13,627 | 12,206 |
| Gross profit | 45,993 | 42,018 | 34,933 | 36,438 |
| Sales and marketing | 25,680 | 23,804 | 21,045 | 18,924 |
| Research and development | 7,565 | 6,853 | 6,091 | 6,996 |
| General and administrative | 10,836 | 9,689 | 9,458 | 10,834 |
| Total costs and expenses | 44,081 | 40,346 | 36,594 | 36,754 |
| Income (loss) from operations | 1,912 | 1,672 | -1,661 | -316 |
| Investment income | 319 | 225 | 272 | 296 |
| Rental income | 0 | - | - | - |
| Interest expense | 1,757 | 1,977 | 2,250 | 1,893 |
| Rental income | - | - | - | 90 |
| Change in fair value of debt derivative liabilities | 209 | 480 | -158 | 13 |
| Other income (expense), net | 25 | 179 | -37 | -48 |
| Total other expense, net | -1,204 | -1,093 | -2,173 | -1,542 |
| Net income (loss) | 708 | 579 | -3,834 | -1,858 |
| Net income (loss) per common share - basic (in usd per share) | 0.02 | 0.01 | -0.08 | -0.04 |
| Net income (loss) per common share - diluted (in usd per share) | 0.01 | 0.01 | -0.08 | -0.04 |
| Weighted average common shares outstanding - basic (in shares) | 46,494,598 | 46,063,092 | 45,204,076 | 43,882,110 |
| Weighted average common shares outstanding - diluted (in shares) | 49,088,436 | 47,980,830 | 45,204,076 | 43,882,110 |
Axogen, Inc. (AXGN)
Axogen, Inc. (AXGN)